Foreword
Introduction of special column “Case Report/Precision Medicine”
Annals of Pancreatic Cancer
2020;
3:
11
(25 August 2020)
Review Article
Systemic and targeted therapies for pancreatic ductal adenocarcinoma
Annals of Pancreatic Cancer
2020;
3:
10
(25 August 2020)
Case Report
Resected metachronous renal metastasis of pancreatic cancer after pancreaticoduodenectomy—a case report
Annals of Pancreatic Cancer
2020;
3:
9
(31 July 2020)
Original Article
Nonselective β-adrenergic blockade impacts pancreatic cancer tumor biology, decreases perineural invasion and improves patient survival
Annals of Pancreatic Cancer
2020;
3:
8
(22 July 2020)
Review Article
Preclinical mouse models for immunotherapeutic and non-immunotherapeutic drug development for pancreatic ductal adenocarcinoma
Annals of Pancreatic Cancer
2020;
3:
7
(22 July 2020)
Review Article
Targeting homologous recombination addicted tumors: challenges and opportunities
Annals of Pancreatic Cancer
2020;
3:
6
(02 June 2020)
Review Article
Landscape of circulating diagnostic biomarkers in pancreatic malignancies
Annals of Pancreatic Cancer
2020;
3:
5
(22 May 2020)
Review Article
Minimally invasive pancreaticojejunostomy techniques: a literature review
Annals of Pancreatic Cancer
2020;
3:
4
(20 May 2020)
Review Article
The present and future of systemic and microenvironment-targeted therapy for pancreatic adenocarcinoma
Annals of Pancreatic Cancer
2020;
3:
3
(20 May 2020)
Original Article
Analyzing outcomes of neoadjuvant and adjuvant treatment for borderline-resectable pancreatic adenocarcinoma in the perioperative period at an academic institution
Annals of Pancreatic Cancer
2020;
3:
2
(09 March 2020)
Editorial
Preface for focused issue: science on pancreatic cancer
Annals of Pancreatic Cancer
2020;
3:
1
(17 January 2020)
Original Article
Adding combination immunotherapy consisting of cancer vaccine, anti-PD-1 and anti-CSF1R antibodies to gemcitabine improves anti-tumor efficacy in murine model of pancreatic ductal adenocarcinoma
Annals of Pancreatic Cancer
2019;
2:
21
(20 December 2019)
Editorial
Bridging clinical medicine with innovative scientific research
Annals of Pancreatic Cancer
2019;
2:
20
(04 December 2019)
News
Application of the CARE guideline as reporting standard in the Annals of Pancreatic Cancer
Annals of Pancreatic Cancer
2019;
2:
19
(25 November 2019)
Review Article
Targeting the epigenome of pancreatic cancer for therapy: challenges and opportunities
Annals of Pancreatic Cancer
2019;
2:
18
(23 October 2019)
Review Article
Evolving trends in pancreatic cancer therapeutic development
Annals of Pancreatic Cancer
2019;
2:
17
(23 October 2019)
Original Article
EUS- versus ERCP-guided biliary drainage for malignant biliary obstruction: evidence from randomized controlled studies
Annals of Pancreatic Cancer
2019;
2:
16
(29 September 2019)
Review Article
Genetics and biology of pancreatic cancer and its precursor lesions: lessons learned from human pathology and mouse models
Annals of Pancreatic Cancer
2019;
2:
15
(22 August 2019)
Review Article
Superior mesenteric artery-first approach with laparoscopic pancreaticoduodenectomy
Annals of Pancreatic Cancer
2019;
2:
14
(19 August 2019)
Review Article
Cellular crosstalk mediating immune evasion in pancreatic cancer microenvironment
Annals of Pancreatic Cancer
2019;
2:
13
(19 July 2019)
Review Article
Insights into the biology and treatment strategies of pancreatic neuroendocrine tumors
Annals of Pancreatic Cancer
2019;
2:
12
(20 June 2019)
Review Article
Ductal vs. acinar? Recent insights into identifying cell lineage of pancreatic ductal adenocarcinoma
Annals of Pancreatic Cancer
2019;
2:
11
(17 June 2019)
Review Article
Multifunctional role of pancreatic stellate cells in pancreatic cancer
Annals of Pancreatic Cancer
2019;
2:
10
(12 June 2019)
Original Article
Partial splenic embolization to alleviate thrombocytopenia in stage III and IV pancreatic ductal adenocarcinoma patients
Annals of Pancreatic Cancer
2019;
2:
9
(11 June 2019)
Original Article
Neutrophil-to-lymphocyte and platelet-to-lymphocyte ratios inversely correlate to clinical and pathologic stage in patients with resectable pancreatic ductal adenocarcinoma
Annals of Pancreatic Cancer
2019;
2:
8
(11 June 2019)